Protection against rotavirus shedding after intranasal immunization of mice with a chimeric VP6 protein does not require intestinal IgA

Virology

Volumn 346, Issue 2, 2006, Pages 338-347

  McNeal, Monica M ^a   Stone, Susan C ^a   Basu, Mitali ^a   Bean, Judy A ^a   Clements, John D ^b   Hendrickson, Barbara A ^c   Choi, Anthony H C ^a   Ward, Richard L ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Intestinal IgA; J chain knockout mice; Rotavirus; VP6 immunization

Indexed keywords

CHIMERIC PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 2; PROTEIN VP6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL POPULATION; CELL SURFACE; CONTROLLED STUDY; EPITHELIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; ROTAVIRUS; SPLEEN CELL; T LYMPHOCYTE; VIRUS INFECTION; VIRUS SHEDDING;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BACTERIAL TOXINS; CAPSID PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHOLERA TOXIN; DISEASE MODELS, ANIMAL; ENTEROTOXINS; ESCHERICHIA COLI PROTEINS; FLOW CYTOMETRY; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERFERON TYPE II; INTERLEUKIN-2; LYMPHOCYTE SUBSETS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; ROTAVIRUS; ROTAVIRUS INFECTIONS; TH1 CELLS; VACCINES, SYNTHETIC; VIRUS SHEDDING;

ANIMALIA; ROTAVIRUS;

EID: 33644819973     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2005.11.016     Document Type: Article

References (52)

1. M.S. Azevedo, L. Yuan, C. Iosef, K.O. Chang, Y. Kim, T.V. Nguyen, and L.J. Saif Magnitude of serum and intestinal antibody responses induced by sequential replicating and nonreplicating rotavirus vaccines in gnotobiotic pigs and correlation with protection Clin. Diagn. Lab. Immunol. 11 1 2004 12 20
2. A. Bertolotti-Ciarlet, M. Ciarlet, S.E. Crawford, M.E. Conner, and M.K. Estes Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice Vaccine 21 25-26 2003 3885 3900
3. J.W. Burns, M. Siadat-Pajouh, A.A. Krishnaney, and H.B. Greenberg Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity Science 272 5258 1996 104 107
4. A.H. Choi, M. Basu, M.M. McNeal, J.D. Clements, and R.L. Ward Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein J. Virol. 73 9 1999 7574 7581
5. A.H. Choi, M.M. McNeal, M. Basu, J.A. Flint, S.C. Stone, J.D. Clements, J.A. Bean, S.A. Poe, J.L. VanCott, and R.L. Ward Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses Vaccine 20 27-28 2002 3310 3321
6. A.H. Choi, M.M. McNeal, J.A. Flint, M. Basu, N.Y. Lycke, J.D. Clements, J.A. Bean, H.L. Davis, M.J. McCluskie, J.L. VanCott, and R.L. Ward The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant Vaccine 20 13-14 2002 1733 1740
7. M. Ciarlet, S.E. Crawford, C. Barone, A. Bertolotti-Ciarlet, R.F. Ramig, M.K. Estes, and M.E. Conner Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity J. Virol. 72 11 1998 9233 9246
8. M.E. Conner, M.A. Gilger, M.K. Estes, and D.Y. Graham Serologic and mucosal immune response to rotavirus infection in the rabbit model J. Virol. 65 5 1991 2562 2571
9. M.E. Conner, D.Y. Graham, and M.K. Estes Determination of the duration of a primary immune response and the ID50 of ALA rabbit rotavirus in rabbits Arch. Virol. 142 11 1997 2281 2294
10. A. Coste, J.C. Sirard, K. Johansen, J. Cohen, and J.P. Kraehenbuhl Nasal immunization of mice with virus-like particles protects offspring against rotavirus diarrhea J. Virol. 74 19 2000 8966 8971
11. B.S. Coulson, K. Grimwood, I.L. Hudson, G.L. Barnes, and R.F. Bishop Role of coproantibody in clinical protection of children during reinfection with rotavirus J. Clin. Microbiol. 30 7 1992 1678 1684
12. S.E. Crawford, M.K. Estes, M. Ciarlet, C. Barone, C.M. O'Neal, J. Cohen, and M.E. Conner Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles J. Virol. 73 6 1999 4813 4822
13. P.H. Dennehy Rotavirus vaccines: an update Curr. Opin. Pediatr. 17 1 2005 88 92
14. N. Feng, P.T. Vo, D. Chung, T.V. Vo, Y. Hoshino, and H.B. Greenberg Heterotypic protection following oral immunization with live heterologous rotaviruses in a mouse model J. Infect. Dis. 175 2 1997 330 341
15. N. Feng, J.A. Lawton, J. Gilbert, N. Kuklin, P. Vo, B.V. Prasad, and H.B. Greenberg Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb J. Clin. Invest. 109 9 2002 1203 1213
16. M.A. Franco, and H.B. Greenberg Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice J. Virol. 69 12 1995 7800 7806
17. C. Fromantin, L. Piroth, I. Petitpas, P. Pothier, and E. Kohli Oral delivery of homologous and heterologous strains of rotavirus to BALB/c mice induces the same profile of cytokine production by spleen cells Virology 244 2 1998 252 260
18. R.I. Glass, J.S. Bresee, U.D. Parashar, B. Jiang, and J. Gentsch The future of rotavirus vaccines: a major setback leads to new opportunities Lancet 363 9420 2004 1547 1550
19. A.M. Gonzalez, T.V. Nguyen, M.S. Azevedo, K. Jeong, F. Agarib, C. Iosef, K. Chang, K. Lovgren-Bengtsson, B. Morein, and L.J. Saif Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOM Clin. Exp. Immunol. 135 3 2004 361 372
20. G.R. Harriman, M. Bogue, P. Rogers, M. Finegold, S. Pacheco, A. Bradley, Y. Zhang, and I.N. Mbawuike Targeted deletion of the IgA constant region in mice leads to IgA deficiency with alterations in expression of other Ig isotypes J. Immunol. 162 5 1999 2521 2529
21. B.A. Hendrickson, D.A. Conner, D.J. Ladd, D. Kendall, J.E. Casanova, B. Corthesy, E.E. Max, M.R. Neutra, C.E. Seidman, and J.G. Seidman Altered hepatic transport of immunoglobulin A in mice lacking the J chain J. Exp. Med. 182 6 1995 1905 1911
22. B.A. Hendrickson, L. Rindisbacher, B. Corthesy, D. Kendall, D.A. Waltz, M.R. Neutra, and J.G. Seidman Lack of association of secretory component with IgA in J chain-deficient mice J. Immunol. 157 2 1996 750 754
23. C. Iosef, T. Van Nguyen, K. Jeong, K. Bengtsson, B. Morein, Y. Kim, K.O. Chang, M.S. Azevedo, L. Yuan, P. Nielsen, and L.J. Saif Systemic and intestinal antibody secreting cell responses and protection in gnotobiotic pigs immunized orally with attenuated Wa human rotavirus and Wa 2/6-rotavirus-like-particles associated with immunostimulating complexes Vaccine 20 13-14 2002 1741 1753
24. B. Jiang, M.K. Estes, C. Barone, V. Barniak, C.M. O'Neal, A. Ottaiano, H.P. Madore, and M.E. Conner Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles Vaccine 17 7-8 1999 1005 1013
25. C.S. Kaetzel, and K. Mostov Immunoglobulin transport and the polymeric immunoglobulin receptor J. Mestecky M.E. Lamm W. Strober J. Bienenstock J.R. McGhee L. Mayer 3rd edition Mucosal Immunol. vol. 1 2005 Elsevier Academic Press New York 211 250 2 vols
26. N.A. Kuklin, L. Rott, N. Feng, M.E. Conner, N. Wagner, W. Muller, and H.B. Greenberg Protective intestinal anti-rotavirus B cell immunity is dependent on alpha 4 beta 7 integrin expression but does not require IgA antibody production J. Immunol. 166 3 2001 1894 1902
27. D.O. Matson, M.L. O'Ryan, I. Herrera, L.K. Pickering, and M.K. Estes Fecal antibody responses to symptomatic and asymptomatic rotavirus infections J. Infect. Dis. 167 3 1993 577 583
28. M.M. McNeal, K.S. Barone, M.N. Rae, and R.L. Ward Effector functions of antibody and CD8+cells in resolution of rotavirus infection and protection against reinfection in mice Virology 214 2 1995 387 397
29. M.M. McNeal, M.N. Rae, and R.L. Ward Evidence that resolution of rotavirus infection in mice is due to both CD4 and CD8 cell-dependent activities J. Virol. 71 11 1997 8735 8742
30. M.M. McNeal, M.N. Rae, J.A. Bean, and R.L. Ward Antibody-dependent and-independent protection following intranasal immunization of mice with rotavirus particles J. Virol. 73 9 1999 7565 7573
31. M.M. McNeal, J.L. VanCott, A.H. Choi, M. Basu, J.A. Flint, S.C. Stone, J.D. Clements, and R.L. Ward CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G) J. Virol. 76 2 2002 560 568
32. J. Mestecky, I. Moro, M.A. Kerr, and J.M. Woof Mucosal immunoglobulins J. Mestecky M.E. Lamm W. Stober J. Bienenstock J.R. McGhee L. Mayer 3rd edition Mucosal Immunol. vol. 1 2005 Elsevier Academic Press New York 154 181 2 vols.
33. T.V. Nguyen, C. Iosef, K. Jeong, Y. Kim, K.O. Chang, K. Lovgren-Bengtsson, B. Morein, M.S. Azevedo, P. Lewis, P. Nielsen, L. Yuan, and L.J. Saif Protection and antibody responses to oral priming by attenuated human rotavirus followed by oral boosting with 2/6-rotavirus-like particles with immunostimulating complexes in gnotobiotic pigs Vaccine 21 25-26 2003 4059 4070
34. C.M. O'Neal, S.E. Crawford, M.K. Estes, and M.E. Conner Rotavirus virus-like particles administered mucosally induce protective immunity J. Virol. 71 11 1997 8707 8717
35. C.M. O'Neal, J.D. Clements, M.K. Estes, and M.E. Conner Rotavirus 2/6 viruslike particles administered intranasally with cholera toxin, Escherichia coli heat-labile toxin (LT), and LT-R192G induce protection from rotavirus challenge J. Virol. 72 4 1998 3390 3393
36. C.M. O'Neal, G.R. Harriman, and M.E. Conner Protection of the villus epithelial cells of the small intestine from rotavirus infection does not require immunoglobulin A J. Virol. 74 9 2000 4102 7109
37. U.D. Parashar, E.G. Hummelman, J.S. Bresee, M.A. Miller, and R.I. Glass Global illness and deaths caused by rotavirus disease in children Emerg. Infect. Dis. 9 5 2003 565 572
38. I. Schwartz-Cornil, Y. Benureau, H. Greenberg, B.A. Hendrickson, and J. Cohen Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins J. Virol. 76 16 2002 8110 8117
39. M. Siadat-Pajouh, and L. Cai Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant Viral Immunol. 14 1 2001 31 47
40. T.L. To, L.A. Ward, L. Yuan, and L.J. Saif Serum and intestinal isotype antibody responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease J. Gen. Virol. 79 Pt. 11 1998 2661 2672
41. J.L. VanCott, M.M. McNeal, J. Flint, S.A. Bailey, A.H. Choi, and R.L. Ward Role for T cell-independent B cell activity in the resolution of primary rotavirus infection in mice Eur. J. Immunol. 31 11 2001 3380 3387
42. R.L. Ward Mechanisms of protection against rotavirus in humans and mice J. Infect. Dis. 174 Suppl. 1 1996 S51 S58
43. R.L. Ward Possible mechanisms of protection elicited by candidate rotavirus vaccines as determined with the adult mouse model Viral Immunol. 16 1 2003 17 24
44. R.L. Ward, and D.I. Bernstein Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines. US Rotavirus Vaccine Efficacy Group Vaccine 13 13 1995 1226 1232
45. R.L. Ward, M.M. McNeal, and J.F. Sheridan Development of an adult mouse model for studies on protection against rotavirus J. Virol. 64 10 1990 5070 5075
46. R.L. Ward, J.D. Clemens, D.R. Knowlton, M.R. Rao, F.P. van Loon, N. Huda, F. Ahmed, G.M. Schiff, and D.A. Sack Evidence that protection against rotavirus diarrhea after natural infection is not dependent on serotype-specific neutralizing antibody J. Infect. Dis. 166 6 1992 1251 1257
47. R.L. Ward, M.M. McNeal, and J.F. Sheridan Evidence that active protection following oral immunization of mice with live rotavirus is not dependent on neutralizing antibody Virology 188 1 1992 57 66
48. R.L. Ward, D.R. Knowlton, E.T. Zito, B.L. Davidson, R. Rappaport, and M.E. Mack Serologic correlates of immunity in a tetravalent reassortant rotavirus vaccine trial. US Rotavirus Vaccine Efficacy Group J. Infect. Dis. 176 3 1997 570 577
49. L. Yuan, and L.J. Saif Induction of mucosal immune responses and protection against enteric viruses: rotavirus infection of gnotobiotic pigs as a model Vet. Immunol. Immunopathol. 87 3-4 2002 147 160
50. L. Yuan, S.Y. Kang, L.A. Ward, T.L. To, and L.J. Saif Antibody-secreting cell responses and protective immunity assessed in gnotobiotic pigs inoculated orally or intramuscularly with inactivated human rotavirus J. Virol. 72 1 1998 330 338
51. L. Yuan, A. Geyer, D.C. Hodgins, Z. Fan, Y. Qian, K.O. Chang, S.E. Crawford, V. Parreno, L.A. Ward, M.K. Estes, M.E. Conner, and L.J. Saif Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs J. Virol. 74 19 2000 8843 8853
52. L. Yuan, C. Iosef, M.S. Azevedo, Y. Kim, Y. Qian, A. Geyer, T.V. Nguyen, K.O. Chang, and L.J. Saif Protective immunity and antibody-secreting cell responses elicited by combined oral attenuated Wa human rotavirus and intranasal Wa 2/6-VLPs with mutant Escherichia coli heat-labile toxin in gnotobiotic pigs J. Virol. 75 19 2001 9229 9238